| Dataset | NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles |
| Category | transcriptomics |
| Type | drug perturbation |
| Description | Dose=1uM, 4-[6-Tert-butylsulfonyl-7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl]-6-chloropyridin-2-amine, Receptor-Interacting Serine/Threonine-Protein (RIP-2) Kinase 2 Inhibitors;SELECTIVE INHIBITOR OF RIPK2 targeting RIPK2 (Novartis, 145949517) |
| External Link | https://pubchem.ncbi.nlm.nih.gov/compound/145949517 |
| Similar Terms | |
| Downloads & Tools |
5 genes differentially expressed following the AD-82-OW73_1uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| TMSB10 | thymosin beta 10 | 0.330923 |
| MT1E | metallothionein 1E | 0.262528 |
| RPS2 | ribosomal protein S2 | 0.253661 |
| SELENOW | selenoprotein W | 0.233331 |
| Symbol | Name | Standardized Value |
|---|---|---|
| UBE2C | ubiquitin-conjugating enzyme E2C | -0.222679 |